Celularity Inc. (CELU)
NASDAQ: CELU · IEX Real-Time Price · USD
5.60
-0.08 (-1.41%)
At close: Mar 18, 2024, 4:00 PM
5.59
-0.01 (-0.18%)
After-hours: Mar 18, 2024, 4:40 PM EDT

Celularity Income Statement

Millions USD. Fiscal year is Jan - Dec.
Year 2022202120202019
Revenue
17.9821.3414.2821.15
Revenue Growth (YoY)
-15.75%49.43%-32.48%-
Cost of Revenue
19.679.654.936.32
Gross Profit
-1.6911.689.3514.82
Selling, General & Admin
66.0271.3431.3441.79
Research & Development
78.3688.3552.7146.05
Other Operating Expenses
5.82.19132.79122.24
Operating Expenses
150.19161.89216.84210.09
Operating Income
-151.88-150.2-207.49-195.26
Interest Expense / Income
03.172.350
Other Expense / Income
-166.08-53.283.0972.73
Pretax Income
14.21-100.1-212.93-267.99
Income Tax
0.010.02-4.7-56.11
Net Income
14.19-100.12-208.23-211.88
Shares Outstanding (Basic)
14722
Shares Outstanding (Diluted)
15722
Shares Change
123.44%264.09%-22.85%-
EPS (Basic)
1.00-14.90-113.10-88.80
EPS (Diluted)
0.90-14.90-113.10-88.80
Free Cash Flow
-143.11-116.3-91.03-98.27
Free Cash Flow Per Share
-10.23-17.34-49.42-41.16
Gross Margin
-9.40%54.76%65.46%70.10%
Operating Margin
-844.93%-704.03%-1453.22%-923.36%
Profit Margin
78.95%-469.27%-1458.42%-1001.94%
Free Cash Flow Margin
-796.17%-545.11%-637.53%-464.69%
Effective Tax Rate
0.09%---
EBITDA
23.58-88.11-202.41-261.81
EBITDA Margin
131.19%-412.98%-1417.60%-1238.04%
Depreciation & Amortization
9.388.828.176.19
EBIT
14.21-96.93-210.58-267.99
EBIT Margin
79.03%-454.31%-1474.85%-1267.29%
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).